Two people familiar with the policy say pharmacies would get temporary cover to make popular peptides, even though FDA staff scientists found them understudied.
Recap by typeshit. Full story at MedPage Today.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
A research letter by Uscher-Pines et al. surveyed 2,009 US adults on GLP-1 use and alcohol. He flags important caveats in reading the results.
New analysis suggests GLP-1 drugs could help people living with schizophrenia, another sign of research moving into mental health.
Loading…